Publication:
Which Rivastigmine Formula is Better for Heart in Elderly Patients With Alzheimer-s Disease: Oral or Patch?

Placeholder

Organizational Units

Program

Authors

Authors

Isik, Ahmet Turan
Soysal, PINAR
YAY, Adnan

Advisor

Date

2014-12-01T00:00:00Z

Language

Type

Article

Publisher

Journal Title

Journal ISSN

Volume Title

Abstract

Objective: Rivastigmine is commonly used for the treatment of Alzheimer-s disease (AD). All cholinesterase inhibitors, including rivastigmine, may cause cardiac side effects. The aim of this study is to compare the electrocardiographic (ECG) and hypotensive effects of formulations of rivastigmine.

Description

Source:

Keywords:

Keywords

Citation

Isik A. T. , Soysal P., YAY A., -Which Rivastigmine Formula is Better for Heart in Elderly Patients With Alzheimer-s Disease: Oral or Patch?-, AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, cilt.29, ss.735-738, 2014

URI

http://hdl.handle.net/20.500.12645/26942

Collections

Yayınlar - Eserler

Endorsement

Review

Supplemented By

Referenced By

0

Views

0

Downloads

View PlumX Details


Sustainable Development Goals